"6 months history not responded to first line treatments (ie medication with lidocaine, anticonvulsants, antidepressants) significant disability and distress" "All of the neuropathic pain beyond ...

MIRA Pharmaceuticals (MIRA) announced that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved treatments ... solutions for neuropathic pain without ...

A new study by Monash University medicine safety experts found the use of gabapentinoids—medicines widely used to treat ...

"Ketamir-2 has the potential not only to address neuropathic pain but also to make a significant impact in the treatment of PTSD and depression. Our goal is to ensure that those who need it most ...

Background Best current estimates of neuropathic pain (NeuP ... trials (three months/maximum tolerated); outcomes of treatment (pain severity, quality of life). Further work needs to validate ...